James R. Kasinger - Net Worth and Insider Trading

James R. Kasinger Net Worth

The estimated net worth of James R. Kasinger is at least $5 Million dollars as of 2026-09-21. James R. Kasinger is the General Counsel and Secretary of CRISPR Therapeutics AG and owns about 94,308 shares of CRISPR Therapeutics AG (CRSP) stock worth over $5 Million. Details can be seen in James R. Kasinger's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James R. Kasinger has not made any transactions after 2026-03-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of James R. Kasinger

To

Are these stocks worth buying? — GuruFocus analysis for each holding

James R. Kasinger Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James R. Kasinger owns 1 companies in total, including CRISPR Therapeutics AG (CRSP) .

Click here to see the complete history of James R. Kasinger’s form 4 insider trades.

Insider Ownership Summary of James R. Kasinger

Ticker Company Transaction Date Type of Owner
CRSP CRISPR Therapeutics AG 2026-03-23 General Counsel and Secretary

James R. Kasinger Latest Holdings Summary

James R. Kasinger currently owns a total of 1 stock. James R. Kasinger owns 94,308 shares of CRISPR Therapeutics AG (CRSP) as of March 23, 2026, with a value of $5 Million.

Latest Holdings of James R. Kasinger

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CRSP CRISPR Therapeutics AG 2026-03-23 94,308 56.56 5,334,060

Holding Weightings of James R. Kasinger


James R. Kasinger Form 4 Trading Tracker

According to the SEC Form 4 filings, James R. Kasinger has made a total of 11 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in CRISPR Therapeutics AG is the sale of 3,182 shares on March 23, 2026, which brought James R. Kasinger around $148,854.

Insider Trading History of James R. Kasinger

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James R. Kasinger Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock James R. Kasinger owns.
View CRSP Analysis

James R. Kasinger Ownership Network

Ownership Network List of James R. Kasinger

No Data

Ownership Network Relation of James R. Kasinger

Insider Network Chart


James R. Kasinger Owned Company Details

What does CRISPR Therapeutics AG do?

Who are the key executives at CRISPR Therapeutics AG?

James R. Kasinger is the General Counsel and Secretary of CRISPR Therapeutics AG. Other key executives at CRISPR Therapeutics AG include Chief Medical Officer Naimish Patel , Chief Financial Officer Raju Prasad , and Chief Business Officer Samarth Kulkarni .

CRISPR Therapeutics AG (CRSP) Insider Trades Summary

Over the past 18 months, James R. Kasinger made 5 insider transaction in CRISPR Therapeutics AG (CRSP) with a net sale of 12,620. Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 195,352 shares made by Samarth Kulkarni , a net sale of 78,249 shares made by Raju Prasad , and a net sale of 9,360 shares made by Naimish Patel .

In summary, during the past 3 months, insiders sold 0 shares of CRISPR Therapeutics AG (CRSP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 297,089 shares of CRISPR Therapeutics AG (CRSP) were sold and 1,011,320 shares were bought by its insiders, resulting in a net purchase of 714,231 shares.

CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CRISPR Therapeutics AG Insider Transactions

No Available Data

James R. Kasinger Mailing Address

Above is the net worth, insider trading, and ownership report for James R. Kasinger. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, James R. Kasinger's mailing address is: Cambridge Ma 02139.